Multiple Sclerosis Trial, Recruiting NCT07252895 Sponsor: Otto Bock France SNC Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT07252895
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been formally diagnosed with Multiple Sclerosis (MS) for at least 3 months, based on recognised medical guidelines (the 2017 McDonald criteria)
  • Your level of disability falls within a specific range on a standard MS disability scale (EDSS score between 4 and 6 — roughly meaning you have some walking difficulty but can still walk, confirm with trial site)
  • Your ability to walk has been stable for at least two weeks before joining, with little change recorded on a standard questionnaire
  • You are not currently taking a medication called fampridine, either because it wasn't suitable for you, caused side effects, didn't work, stopped working, or you prefer not to take it
  • You have muscle stiffness (spasticity) in at least one muscle group in your lower limbs, confirmed by a standard medical assessment
  • You have never previously used the EXOPULSE SUIT device

Who may not be able to join:

  • You are under 18 years old
  • You have a medical reason that makes using the EXOPULSE SUIT unsafe for you
  • You use an electronic device that keeps you alive or regulates your heart (such as a pacemaker), high-frequency surgical equipment, or a heart-monitoring (ECG) device
  • You have other significant physical or mental health conditions, such as uncontrolled epilepsy, irregular heart rhythm, or conditions causing bone, joint, or muscle pain
  • You have had an MS relapse (a flare-up of symptoms) in the 3 months before joining
  • Your MS medications or treatments affecting movement have been changed or a new one started in the 3 months before joining
  • You have had botulinum toxin (Botox) injections in your leg muscles in the 4 months before joining
  • You are planning to start using a new medical device (such as an ankle-foot brace) during the study
  • You are currently doing, or planning to do, an intensive rehabilitation programme
  • You are already taking part in another research study
  • The EXOPULSE SUIT does not come in a size that fits you (for example, if your BMI is over 35, your height is under 100 cm or over 205 cm)
  • You do not have a smartphone, or are unable or unwilling to use one to operate the EXOPULSE app
  • You are not able to attend all of the required medical visits throughout the study
  • You are unable to understand spoken and written French
  • You are pregnant
  • You are under legal guardianship or protection (confirm with trial site)
  • You are currently in prison

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Samar AYACHE, Pr, CHU Henri Mondor

Phone: 0033 (0)7 86 29 52 03

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Otto Bock France SNC
Registry
ClinicalTrials.gov
Start date
30 March 2026
Est. completion
1 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

The Multiple Sclerosis Walking Scale 12 (MSWS-12)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov